Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZC3H3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | GAREM2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | CACNG6 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | ZDHHC8 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | EPG5 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | SDC1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | ATP8B3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | LAIR1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | NUMA1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | DPM1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |